Simcere Zaiming, Inc. sold $185k of NXTC
other at NextCure, Inc.. 30,000 shares at an average of $6.16, traded Aug 10, 2026, filed Aug 12, 2026.
Score components
- +8RoleOther
- +12Trade size$185k at market
- 0Share of holdings soldSold 8.9% of holdings
- 0ClusterNo other insider selling within 14 days
- +10Role exitThe filing reports the insider leaving
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-088156, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | SOpen-market sale Common Stockindirect: See Footnotes | -30,000 | $6.16 | $185k | 308,636 | Aug 12, 2026 |
Related signals
Other insiders at NextCure, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | NXTCbuy NextCure, Inc. | ADAR1 Capital Management, LLC owner | $1.6M 329,153 shares | +84% | |
| 16Weak | NXTCbuy NextCure, Inc. | ADAR1 Capital Management, LLC owner | $88k 17,608 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.